The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 18, 2022
Filed:
Sep. 30, 2015
Applicant:
Eagle Biologics, Inc., Cambridge, MA (US);
Inventors:
Alyssa M. Larson, Dana Point, CA (US);
Kevin Love, Boston, MA (US);
Alisha K. Weight, Mill Creek, WA (US);
Alan Crane, Waban, MA (US);
Robert S. Langer, Newton, MA (US);
Alexander M. Klibanov, Boston, MA (US);
Assignee:
Eagle Biologics, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/727 (2006.01); A61K 31/721 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/715 (2006.01); A61K 31/7088 (2006.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 31/722 (2006.01); A61K 31/724 (2006.01); A61K 31/728 (2006.01); A61K 31/734 (2006.01); A61K 31/737 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 31/727 (2013.01); A61K 9/0019 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 31/715 (2013.01); A61K 31/7105 (2013.01); A61K 31/722 (2013.01); A61K 31/724 (2013.01); A61K 31/728 (2013.01); A61K 31/734 (2013.01); A61K 31/737 (2013.01); A61K 45/06 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01);
Abstract
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of polysaccharides and nucleic acids have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include low-molecular-weight and/or high-molecular-weight polysaccharides and nucleic acids, and viscosity-lowering agents.